SLU-PP-332 is an investigational small-molecule compound studied for its activity as a selective estrogen-related receptor (ERR) agonist, particularly targeting ERRα, ERRβ, and ERRγ pathways. In laboratory and preclinical research settings, activation of these nuclear receptors has been associated with enhanced mitochondrial function, increased oxidative metabolism, and shifts in cellular energy utilization similar to those observed during endurance exercise signaling pathways. Because of these properties, SLU-PP-332 has drawn interest among researchers studying metabolic regulation, energy expenditure, and skeletal muscle bioenergetics.

This compound is intended strictly for laboratory and research purposes only.